HER-2/NEU EXPRESSION IN PROSTATE CANCER:
- 1 October 2001
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- p. 1514-1519
- https://doi.org/10.1097/00005392-200110000-00083
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- From HER2/Neu signal cascade to androgen receptor and its coactivators: A novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cellsProceedings of the National Academy of Sciences, 1999
- Treatment of prostate cancerJournal of Clinical Pharmacy & Therapeutics, 1999
- New pieces to the prostate cancer puzzleNature Medicine, 1999
- A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinaseNature Medicine, 1999
- The HER‐2/ neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for TherapyThe International Journal of Cell Cloning, 1998
- Prognostic significance of HER-2/neu gene amplification status by fluorescence in Situ hybridization of prostate carcinomaCancer, 1997
- p53, c-erbB-2 and the Epidermal Growth Factor Receptor in the Benign and Malignant ProstateJournal of Urology, 1992
- Expression of c‐erb B‐2/neu proto‐oncogene in human prostatic cancer tissues and cell linesMolecular Carcinogenesis, 1992
- MINIREVIEW: Estrogen Receptor Variants in Clinical Breast CancerMolecular Endocrinology, 1991
- A critical analysis of tumor morphology and hormone treatments in the untreated and estrogen-treated responsive and refractory human prostatic carcinomaCancer, 1977